SINGLE-DOMAIN BRAIN-TARGETING ANTIBODY FRAGMENTS DERIVED FROM LLAMA ANTIBODIES

Details for Australian Patent Application No. 2001267180 (hide)

Owner NATIONAL RESEARCH COUNCIL OF CANADA

Inventors MURUGANANDAM, Arumugam; TANHA, Jasmid; NARANG, Saram; STANIMIROVIC, Danica

Pub. Number AU-A-2001267180

PCT Pub. Number WO2002/057445

Priority 60/207,234 26.05.00 US; 60/263,108 22.01.01 US

Filing date 25 May 2001

Wipo publication date 30 July 2002

International Classifications

C12N 015/10 Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

C07K 016/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

G01N 033/577 Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2001267180

8 January 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001267181

2001267179